Home Clinical Practice Diabetes Education Clinical Research Physician Profiles What's New? F-A-Q's Map to DGD |
Firas Akhrass MD |
Practice
February, 2007-present Diabetes &Glandular Disease Clinic
Endocrinology & Diabetes
5107 Medical Dr
San Antonio, TX 78229
210-614-8612
July, 2003-February, 2007 Dodge City Medical Center
Endocrinology
Dodge City, KS
July, 2001-June, 2003 Fellowship in Endocrinology
Board Certified in Endocrinology 2003
Rush Presbyterian-St. Luke’s University
Chicago, Illinois
July, 1999- June, 2001 Residency in Internal Medicine
Board Certified in Internal Medicine 2001
Union Memorial Hospital
Baltimore, Maryland
July, 1998 – June, 1999 Transitional Year Residency Program
Michigan State University-Sparrow Hospital
East Lansing, Michigan
.
July, 1987 – December, 1993 School of Medicine, Aleppo University Hospital Aleppo, Syria
Doctor of Medicine
Graduated in the top 10% of the class
Additional Experience
July, 2001 to June 2003 Research Assistant: Co-Investigator
Rush Presbyterian-St. Luke’s University
Chicago, Illinois
Navigator Study: Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research.
July, 2001 to June 2003 Research Assistant: Co-Investigator
Department of Endocrinology Cook County Hospital
Chicago, Illinois
Lantus (insulin glargine [rDNAorigin] injection) vs. Humalog Mix 75/25 (75% insulin lispro protamine suspension and 25%insulin lispro injection) as Add-On Therapy in Type 2 Diabetes Patients Failing Sulfonylurea and Glucophage (metformin) Combination Treatment: A Randomized, Open, Parallel Study
A Study to Evaluate the Efficacy of Rosiglitazone (trade name Avandia) on Reduction of Microalbuminuna in Patients with Type 2 Diabetes Mellitus”
“A Randomized, Double —blind Study to Compare the Durability of Glucose-lowering and Preservation of Pancreatic Beta-cell Function of Rosiglitazone (trade name Avandia)
Monotherapy Compared to Metformin or Glyburide in Patients with Drug naive, Recently Diagnosed Type 2 Diabetes Mellitus”
A Phase 3, Randomized, Triple-Blind, Parallel-Group, Long-Term, Placebo-Controlled, Multicenter Study to Examine the Effect on Glucose Control (HbAlc) of AC2993 Given Twice Daily in Subjects With Type 2 Diabetes Mellitus Treated with Metformin and Sulfonylurea.”
January, 1996 – June, 1999 Research Assistant
Department of Medicine, Michigan State University East Lansing, Michigan
Assisted in planning, organizing, analyzing and reviewing data using SPSS, and participated in writing manuscripts included in the MSU Inter-Institutional Collaborative Heart (MICH) Study including:
Under Utilization of Lipid Lowering Drugs in Patients with CAD in Community Hospital.
The severity of Coronary Artery Disease and The Number of Risk Factors in Patients with Acute MI.
Assisted in planning and designing the study, and the instruments. Trained nurses how to use the instruments effectively, and how to perform the interviews uniformly.
Manuscripts written include:
Conducted experiments and applied imaging technology to study vasoreactivity of arteries in rabbit models. Analyzed data utilizing Sigma Plot; co-authored
B-Carotene Preserves Endothelium Dependant Relaxation in an Atherosclerotic Model of Plaque Disruption and Thrombosis
The Journal of Clinical Endocrinology and Metabolism 2003;88 5611-5614.
F. Akhrass, M.D., N. Elsouri, M.D., P. Slone, M.D.
A Rare Case of Acute Interstitial Pneumonitis, Mediastinal and Subcutaneous Emphysema as a Presenting Illness of Systemic Lupus Erythematosus
F. Akhrass, M.D., D. Wadwani, M.D.
Quantitative Analysis of Blood Wastage as a Result of Diagnostic Phlebotomy, What Can be Done?
N. Rasouli, M.D., F. Akhrass, M.D., H Al-Rubaiai, H. El-Tamimi M.D.
Unstable Angina and the Use of Therapeutic Modalities in Community Hospital.
American College of Physicians, Michigan Chapter, 1999.
E. Korban, H. Ma, A. Prieto. X. Qiao, F. Akhrass M.D., G. Abela M.D.
B-Carotene Preserves Endothelium Dependent Relaxation in an Atherosclerotic Model of Plaque Disruption and Thrombosis
American College of Physicians, Michigan Chapter, 1999.
Licensure and Certification
Board Certified in Internal Medicine in 2001
Board Certified in Endocrinology, Diabetes and Metabolism in 2003
Membership: International Society for Clinical Densitometry
Membership: The Endocrine Society
Membership: The American Association of Clinical Endocrinologists
Home Clinical Practice Diabetes Education Clinical Research Physician Profiles What's New? F-A-Q's Map to DGD |
© 1979- 2007 DGD